Gene Query: EPB41L1

Dataset Description Geneva Score
H1609088 Human RNA-Sequencing 96.21
G-quadruplex structures mark human regulatory chromatin 66.41
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 63.2
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 62.7
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 60.47
RNA-sequencing of human liver tissue 54.94
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 48.17
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 44.95
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 41.34
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 39.99
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 39.99
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 39.62
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 37.85
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 36.54
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 36.54
Gene expression changes after LOC550643 silencing 34.71
METTL3 promotes translation in human cancer cells 34.42
Nutritional control of protein translation 34.08
Nrf2 regulated genes in A549 cells 32.83
Identification of Nrf2 regulated genes by RNA sequencing 32.83
Differentially expressed genes post knock down of lincDUSP26 32.01
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 30.9
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 29.69
Effect of Influenza virus infection on lncRNA expression in A549 cells 27.81
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 27.03
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 26.94
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 26.48
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 26.44
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 25.08
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 25.08
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 24.51
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 24.48
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 24.34
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 24.12
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 24.12
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 23.5
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 23.5
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 23.25
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 23.22
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 23.21
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 23.2
Gene expression analysis of the impact of TDP-43 knockout in human cells. 23.19
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 23.12
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 22.53
circRNA-sequencing 22.2
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 22.09
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 22.07
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 22.03
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 21.96
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 21.66
Differetially expressed genes after hTR overexpression in U2OS cells 21.6
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 21.56
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 21.56
Transcriptional profiling of LS1034 cells treated with tepoxalin 21.05
Examining serotonergic neuron differentiation from human iPSCs 20.97
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 20.9
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 20.9
Tyrosine Kinase Inhibitor Cardiotoxicity 20.41
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 20.41
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 20.27
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 20.16
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 20.01
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 19.99
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 19.65
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 18.97
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 18.53
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 18.53
Transcriptomic analysis of LSD1 18.44
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 18.39
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 18.39
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 18.35
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 17.89
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 17.89
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 17.77
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 17.75
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 17.75
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 17.7
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 17.7
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 17.53
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 17.53
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 17.11
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 17.09
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 17.09
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 16.93
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 16.63
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 16.5
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 16.49
CD73 knockdown effect in pancreatic cancer cell lines 16.31
Genome-wide analysis of Dengue virus 2 infected cells 16.27
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 16.27
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 16.24
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 16.09
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 15.87
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 15.87
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 15.87
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 15.82
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 15.66
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 15.34
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 15.32
Analysis of transcriptional regulation by Myt1 and Myt1l 15.18
GATA3-mediated chromatin reprogramming in breast cancer cells 15.14
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 15.13
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 15.02
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 14.67
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 14.5
An integrative analysis of non-coding regulatory DNA variations associated with autism 14.46
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 14.45
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 14.41
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 14.39
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 14.27
Transcriptome-wide identification of CELF2 functional targets in T cells 14.23
Neurofibroma 14.1
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 14.1
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 14.03
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 13.83
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 13.83
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 13.77
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 13.77
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 13.73
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 13.73
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 13.7
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 13.61
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 13.6
RNA-seq in transgenic cells 13.59
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 13.58
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 13.58
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 13.58
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 13.55
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 13.55
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 13.2
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 13.2
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 13.03
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 13.03
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 13.02
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 12.93
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 12.87
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 12.87
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 12.83
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 12.76
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 12.53
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 12.45
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 12.44
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 12.3
Alteration of the microRNA network during the progression of Alzheimer’s disease 12.28
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 12.23
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 12.18
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 12.1
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 12.07
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 12.06
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 12.04
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 12.01
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 11.96
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 11.96
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 11.81
Differentiation enhances Zika virus infection in neuronal brain cells 11.76
Differential Gene Expression between MCF10A and MCF7 cells 11.76
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 11.7
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 11.7
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 11.68
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 11.64
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 11.56
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 11.49
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 11.45
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 11.44
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 11.29
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 11.28
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 11.27
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 11.24
SUV420H2 knockdown in PANC-1 11.23
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 11.22
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 11.21
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 11.18
Universal alternative splicing of noncoding exons 11.16
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 11.07
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 11.02
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 10.8
RNA-seq analysis to identify the genes regulated by p53-SET interplay 10.79
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 10.7
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 10.7
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 10.6
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 10.58
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 10.58
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 10.58
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 10.58
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 10.49
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 10.49
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 10.48
IDH3a KO RNA-seq 10.48
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 10.47
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 10.43
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 10.42
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 10.32
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 10.21
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 10.17
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 10.13
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 10.06
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 10.06
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 10.02
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 9.9
ARID1A and ARID1B loss in HCT116 cells 9.89
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 9.87
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 9.87
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 9.77
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 9.75
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 9.7
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 9.69
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 9.69
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 9.69
Transcriptome analysis of U87 cells upon LINC00152 knockdown 9.67
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 9.53
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 9.49
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 9.48
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 9.48
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 9.47
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 9.44
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 9.4
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 9.39
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 9.39
Selective expression of long non-coding RNAs in a breast cancer cell progression model 9.38
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 9.37
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 9.36
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 9.36
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 9.3
Tumor exosome integrins determine organotropic metastasis 9.3
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 9.27
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 9.24
AUF-1 affected genes in human skin cells 9.14
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 9.11
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 9.03
Transcriptomic analyssis following EHMT1/2 inhibition 9.02
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 9.01
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 8.92
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 8.9
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 8.9
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 8.89
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 8.86
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 8.82
Chromatin landscape of human visceral and subcutaneous adipocytes 8.81
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 8.8
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 8.8
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 8.8
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 8.76
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 8.74
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 8.73
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 8.72
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 8.69
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 8.68
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 8.66
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 8.65
Silencing SPIB in attached and floating state of H1703 lung cancer cells 8.59
NAPRT activation of macrophages 8.59
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 8.56
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 8.56
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 8.56
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 8.54
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 8.53
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 8.53
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 8.53
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 8.53
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 8.53
Rorc disruption in human FG pancreatic cancer cells 8.47
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 8.47
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 8.44
MCF-7 as a model for functional analysis of breast cancer risk variants 8.35
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 8.34
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 8.23
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 8.21
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 8.17
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 8.17
Transcriptome of U251 cells overexpression complement component 7 8.12
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 8.08
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 8.07
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 8.05
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 8.04
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 8.03
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 8.02
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 8.0
Transcriptomic analysis of ERR alpha orphan nuclear receptor 7.97
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 7.93
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 7.92
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 7.91
IRF1 regulates IFN dependent and independent gene expression 7.9
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 7.89
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 7.89
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 7.74
Evolution of a transcriptional regulator from a transmembrane nucleoporin 7.69
RNA-seq in HepG2 and IMR90 cells 7.69
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 7.69
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 7.69
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 7.64
LINE-2 transposable elements are a source of functional human microRNAs and target sites 7.59
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 7.53
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 7.48
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 7.48
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 7.44
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 7.42
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 7.41
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 7.41
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 7.29
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 7.29
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 7.21
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 7.2
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 7.13
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 7.13
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 7.06
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 7.05
Conservative alteration of chromosomal expression pattern across human solid tumor types 6.87
Generation of KRAS signatures using immortalized isogenic lung cells. 6.86
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 6.85
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 6.85
Electronic cigarettes 6.8
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 6.75
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 6.69
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 6.69
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 6.69
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 6.69
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 6.63
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 6.54
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 6.54
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 6.53
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 6.47
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 6.43
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 6.43
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 6.38
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 6.38
MCF10A H-Ras RNA-Seq 6.36
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 6.34
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 6.29
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 6.27
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 6.2
An siRNA screen identifies CHD4 as a target for epigenetic therapy 6.18
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 6.15
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 6.15
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 6.11
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 6.11
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 6.1
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 6.01
nELAVL HITS-CLIP in Alzheimer's Disease patients 5.97
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 5.94
Exploring ILF2 regulatory genes by next-generation sequencing 5.89
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 5.83
Gene expression profile in breast cancer cell lines using RNA sequencing 5.76
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 5.72
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 5.71
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 5.69
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 5.62
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 5.62
Transcriptomic profiling of human peripheral blood-derived mast cells 5.49
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 5.49
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 5.46
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 5.46
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 5.38
The Glioma-Infiltrating T Cell Receptor Repertoire 5.34
Macrophage Ad5f35 M2 Challenge 5.29
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 5.28
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 5.2
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 5.16
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 5.16
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 5.14
Selective suppression of endothelial cytokine production by progesterone receptor 5.14
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 5.12
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 5.12
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 5.11
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 5.02
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 4.99
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 4.95
Transcriptome of human white and brown adipose tissue biopsies 4.88
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 4.86
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 4.86
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 4.84
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 4.67
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 4.67
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 4.61
Engineering Patient-Specific Tissue Implants 4.61
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 4.55
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 4.49
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 4.47
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 4.45
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 4.4
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 4.38
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 4.37
NHLRC1 re-expression in cancer cells 4.35
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 4.27
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 4.27
Iron response of HepG2 cells 4.26
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 4.23
RNA-seq analysis of the human fetal kidney. 4.2
Co-regulation of splicing by Rbfox1 and hnRNP M 4.1
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 4.1
FGF2 regulation of gene expression in stable inducible Neurons 3.97
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 3.97
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 3.87
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 3.87
RNA-Seq analysis of human colorectal cancer with liver metastasis 3.85
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 3.85
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 3.84
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 3.79
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 3.71
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 3.7
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 3.52
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 3.52
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 3.51
Repurposing of promoters and enhancers during mammalian evolution 3.39
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 3.35
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 3.34
Widespread regulated alternative splicing of single codons accelerates proteome evolution 3.31
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 3.28
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 3.24
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 3.12
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 3.12
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 3.12
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 3.08
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 3.08
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 3.04
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 3.04
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 2.99
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 2.99
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 2.97
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 2.96
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 2.93
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.72
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 2.71
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 2.7
Gene expression analysis of human hepatocellular cancers 2.58
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 2.55
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 2.5
Finding missing proteins from epigenetically manipulated human cells 2.5
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 2.39
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 2.33
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 2.33
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 2.16
Gene expression profile of CRC-derived HILEC 2.1
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 2.0
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 2.0
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 1.97
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 1.91
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 1.91
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.76
Transcriptome profiling of A2M treated A549 Cell Line Samples 1.72
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 1.69
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 1.69
Generation and functional characterization of MDSC-like cells 1.64
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 1.63
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 1.56
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 1.56
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 1.48
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 1.47
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 1.47
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 1.45
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 1.44
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 1.33
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 1.32
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 1.32
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 1.31
Macrophage Ad5f35 PhenoMap 1.31
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 1.27
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 1.24
Gene expression of collecting duct carcinoma of the kidney 1.22
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 1.19
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 1.19
Expression profiling of converted and control dermal BJ fibroblasts 1.19
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 1.17
Transcriptomic analysis of human macrophages in 3D 1.16
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 1.14
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 1.11
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 1.01
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 1.0
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 0.98
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.98
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.96
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.95
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 0.92
BMS-470539 on human synovial fibroblasts 0.89
Profiling of escape kinetics of viruses subjected to RNAi 0.87
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 0.86
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 0.83
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.8
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 0.79
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.76
RNA sequencing of human pancreatic cancer cell lines 0.73
Effect of nuclear IL-33 on gene expression 0.7
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.64
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 0.61
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 0.55
mRNA sequencing of oropharyngeal cancer cell lines 0.53
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 0.52
The bromodomain protein BRD4 regulates splicing during heat shock 0.52
RNA-Seq and expression data from human adipose tissue 0.42
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.42
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.35
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.33
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.25
RNA-seq of MCF10A cells and CAF 0.21
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 0.17
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.15
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 0.08
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.06
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.05
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 0.05
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 0.04


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation